We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MOH:ATHEXMOTOR OIL (HELLAS) CORINTH REFINERIES S.A. Analysis

Data as of 2026-03-15 - not real-time

$149.20

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Molina Healthcare is trading in a bearish technical environment, with the short‑term moving average below the longer‑term moving average and a neutral RSI that signals no clear overbought or oversold condition. MACD has turned modestly positive, hinting at a fleeting bullish impulse, yet price remains near a key support zone and volume is trending downwards, underscoring weakening momentum.
Fundamentally, the company’s price‑to‑earnings multiple sits comfortably below the sector average, suggesting relative valuation attractiveness, but operating margins are still in the red and cash flow generation is negative, raising questions about near‑term profitability. Recent earnings missed expectations and guidance fell short, prompting a sharp price drop and a wave of analyst downgrades, while the lack of a dividend eliminates income‑focused appeal. The stock’s beta is minimal, indicating low market correlation, but its high volatility and substantial historical drawdown amplify risk, especially given the regulatory sensitivity of Medicaid and Medicare contracts.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Recent earnings miss and weak guidance
  • Bearish technical alignment and decreasing volume
  • Elevated price volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Valuation advantage relative to peers
  • Potential upside from strategic wins and buyback activity
  • Ongoing regulatory uncertainty in Medicaid reimbursement

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term demand for government‑backed health plans
  • Improving revenue growth trajectory
  • Low beta suggesting limited market‑wide downside

Key Metrics & Analysis

Financial Health

Revenue Growth7.10%
Profit Margin1.08%
P/E Ratio16.7
ROE11.02%
ROA3.14%
Debt/Equity99.44
P/B Ratio1.9
Op. Cash Flow$-535000000
Free Cash Flow$-100000000
Industry P/E26.2

Technical Analysis

TrendBearish
RSI48.2
Support$128.38
Resistance$158.59
MA 20$146.77
MA 50$164.15
MA 200$185.67
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Target Price$150.65
Upside/Downside0.97%
GradeFair
TypeBlend

Risk Assessment

Beta0.04
Volatility98.92%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.